Search Tag: Jim Kelly

Executive Health Management

2023 11 Apr

Theravance Biopharma, Inc. announced the appointment of Jim Kelly, Managing Director at Weiss Asset Management, the Company's second largest shareholder, to its Board of Directors. With the appointment of Mr. Kelly, four new directors have joined the Company's Board of Directors since 2018 as part of its ongoing board refreshment process. "We are...Read more